| 000 | 01674 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517144333.0 | ||
| 264 | 0 | _c20170509 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1537-6613 | ||
| 024 | 7 |
_a10.1093/infdis/jiw641 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShay, David K | |
| 245 | 0 | 0 |
_aComparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _c02 2017 |
||
| 300 |
_a510-517 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfluenza A Virus, H3N2 Subtype |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aInfluenza, Human _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedicare |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeasons |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aChillarige, Yoganand | |
| 700 | 1 | _aKelman, Jeffrey | |
| 700 | 1 | _aForshee, Richard A | |
| 700 | 1 | _aFoppa, Ivo M | |
| 700 | 1 | _aWernecke, Michael | |
| 700 | 1 | _aLu, Yun | |
| 700 | 1 | _aFerdinands, Jill M | |
| 700 | 1 | _aIyengar, Arjun | |
| 700 | 1 | _aFry, Alicia M | |
| 700 | 1 | _aWorrall, Chris | |
| 700 | 1 | _aIzurieta, Hector S | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 215 _gno. 4 _gp. 510-517 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/jiw641 _zAvailable from publisher's website |
| 999 |
_c27002982 _d27002982 |
||